Health

STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment

Committee Chair Bill Cassidy of Louisiana says he’s undecided and has called Overton’s role in shaping the Trump administration’s vaccine policies “almost disqualifying,” STAT’s Margaret Manto writes.

✦ Extractive summary — built from the sources' own reporting•From 1 source•1 min read•Updated November 12, 2026, 4:31 PM UTC
Key points
  • Continue to STAT+ to read the full story….
  • The song “ Donnie Darko ” by Let’s Eat Grandma was on repeat during the making of this Readout.
  • The FDA has shelved the Commissioner’s National Priority Voucher program, according to Reuters.

Heidi Overton’s FDA nomination faces a tight vote The Senate health committee will vote next Wednesday on Heidi Overton’s nomination to lead the FDA, and Republicans still aren’t all on board.

Current Chief Medical Officer Cristian Massacesi has been given the additional title of head of R&D.

Additional details
  • A single Republican defection could sink the nomination if every Democrat votes against her.
  • The need-to-know this morning Bristol Myers Squibb has made changes to its R&D structure.
  • Robert Plenge, Bristol’s chief of research, will depart the company in March.
  • Want to stay on top of the science and politics driving biotech today?
  • Sign up to get our biotech newsletter in your inbox.

How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →

Advertisement

Every article behind this summary — 1 article from 1 outlet